Latest news with #ElectronicHealthRecords
Business Wire
16-07-2025
- Health
- Business Wire
Stephenson Global Scholar Grants Program Awards $5.3 Million to Drive Breakthroughs in Pancreatic Cancer Research
LOS ANGELES--(BUSINESS WIRE)--The Stephenson Global Pancreatic Cancer Research Institute and its partner City of Hope, one of the country's largest and most advanced cancer research and treatment organizations, today announced the six inaugural recipients of the prestigious Stephenson Scholar Grants, awarding $5.25 million to support high-impact research aimed at transforming the understanding, early detection and treatment of pancreatic cancer. The grants support a new generation of research that is collaborative, cross-institutional, and deeply innovative. The 2025 recipients are tackling some of the most urgent and complex challenges in pancreatic cancer—from using AI to flag high-risk patients for screening, to developing dual-targeting CAR T cells that attack both tumors and their fibrotic defenses, to uncovering how diabetes-linked DNA damage may trigger cancer. Their work spans early detection, immunotherapy, metabolic vulnerabilities, and precision medicine—and reflects the kind of interdisciplinary, translational science that is urgently needed to improve outcomes for patients. 2025 Stephenson Scholar Grant Recipients Dr. Renier Brentjens and Dr. Leonid Cherkassky (Roswell Park) Engineering Circuit-controlled T Cell Differentiation and Restructuring the Pancreatic Cancer Stroma to Optimize PDAC-targeted CAR T Cell Therapy for Clinical Translation Creating next-generation CAR T cells that target both pancreatic tumors and their fibrotic stroma, using synthetic promoters to fine-tune T cell behavior, offering a promising new direction for pancreatic cancer immunotherapy. Dr. Robert Grant (Princess Margaret/UHN) Applying Artificial Intelligence to Electronic Health Records to Guide Pancreatic Cancer Screening Utilizing large language models to analyze EHR data and flag high-risk individuals for screening—embedding AI directly into hospital systems to enable scalable early detection. Dr. Costas Lyssiotis (University of Michigan) Lysosomal Lipid Homeostasis is a Clinically Exploitable Vulnerability in KRAS-Inhibited Pancreatic Cancer Targeting a unique metabolic vulnerability in KRAS-mutant tumors using clinically relevant drugs and synthetic lethality, with durable cures shown in preclinical models. Dr. Sarah Shuck (City of Hope) From Blood Sugar to Tumor Growth: How Diabetes Fuels Pancreatic Cancer Onset Investigating how the sugar byproduct methylglyoxal leads to DNA mutations associated with pancreatic cancer and developing a novel blood-based screening tool. Dr. Matthew Vander Heiden (MIT) Assessment of Pancreas Organ Health for Pancreatic Cancer Early Detection Developing a multimodal platform that combines stool, blood, and CT imaging to detect pancreatic cancer before symptoms appear and leveraging changes in organ function as early warning signs. Dr. Forest White & Dr. Tyler Jacks (MIT) Identification of Treatment-Associated Tumor Antigens for Targeted Immunotherapy in Pancreatic Cancer Using mass spectrometry to identify new peptide antigens that emerge after KRAS inhibition, enabling novel vaccine and BiTE strategies that link targeted therapy with immunotherapy. 'These scientists' pioneering approaches represent the future of pancreatic cancer research,' said A. Emmet Stephenson Jr., co-founder of SGPCRI. 'Their work exemplifies the kind of innovative, collaborative thinking that the Stephenson initiative was created to support.' 'Pancreatic cancer took my mother far too soon, but my father and I know that groundbreaking science can change the future for so many other families who have faced this disease,' said Tessa Stephenson Brand. 'These grants are about hope, urgency, and the belief that progress is possible.' The Stephensons made their investment in honor of Toni Stephenson, loving wife and mother who, after surviving lymphoma, passed away from pancreatic cancer in 2020. 'Pancreatic cancer remains one of the most challenging diseases to detect and treat, but we are making meaningful progress,' said Dr. Matthew Vander Heiden, the Lester Wolfe Chair in Molecular Biology and Professor of Biology at MIT. 'We're particularly encouraged by the potential to identify changes in normal pancreas function that could enable earlier detection—when treatment is most effective. The opportunity to rigorously test this idea is incredibly exciting, and I'm deeply grateful to the Stephenson Global Pancreatic Cancer Research Institute for supporting this ambitious work. Their investment in innovative research is helping move discoveries closer to the patients who need them most.' A Collaborative Vision for a Global Challenge The Stephenson Scholar Grants represent the largest source of private funding for pancreatic cancer research around the globe. Pancreatic cancer remains the deadliest cancer with a five-year survival rate of just 13% in the United States, impacting hundreds of thousands of families each year. The grants come at a time when federal funding for cancer research—already disproportionately low for pancreatic cancer—is facing an uncertain future. These grants reflect the Institute's commitment to building a global, collaborative research ecosystem. This year's recipients span leading institutions in the U.S. and Canada, and their projects are designed to bridge disciplines, labs, and clinical settings. The winners were selected from a competitive pool of 188 applications spanning six continents, following a rigorous review by the Stephenson Scientific Advisory Board, comprising some of the world's foremost experts in pancreatic cancer. The grants are part of a broader vision launched with a transformative $150 million gift from A. Emmet Stephenson Jr. and Tessa Stephenson Brand to accelerate discovery, foster partnership, and bring hope to patients and families worldwide. They selected City of Hope, a National Cancer Institute-designated comprehensive cancer center with a national footprint, to help facilitate the SGPCRI's various initiatives and bring together pancreatic cancer leaders in the search for new breakthroughs. 'Congratulations to the inaugural recipients of the Stephenson Global Scholar Grants,' said Daniel D. Von Hoff, M.D., chair of the Stephenson Scientific Advisory Board and distinguished professor at the Translational Genomics Research Institute, part of City of Hope. 'These awards support transformative approaches—from assessing pancreatic health and enabling earlier detection to advancing the latest immunotherapies. There has never been a more important time to unite around high-impact science. This teamwork between visionary philanthropists and some of the world's leading cancer institutions is bringing us closer to a future where pancreatic cancer is no longer a death sentence. We are also deeply grateful to the members of the Scientific Advisory Board for their wisdom and thoughtful deliberation in guiding this effort.' For more information about the Stephenson Global Pancreatic Cancer Research Institute and the Stephenson Global Scholar Grants, visit About the Stephenson Global Pancreatic Cancer Research Institute The Stephenson Global Pancreatic Cancer Research Institute (SGPCRI) is dedicated to transforming the future of pancreatic cancer research through groundbreaking innovation, global collaboration and strategic funding initiatives. Established through a transformative $150 million gift from philanthropists A. Emmet Stephenson Jr. and Tessa Stephenson Brand, SGPCRI is committed to advancing early detection, pioneering treatments and high-impact research to improve patient outcomes. Working with leading scientists, clinicians and institutions worldwide, SGPCRI fosters collaboration to accelerate breakthroughs in the fight against one of the world's most challenging cancers. For more information, visit us on our website or follow us on LinkedIn and X.
Observer
08-07-2025
- Business
- Observer
Digital healthcare booming
The global healthcare market is undergoing a massive paradigm shift from the conventional way to digital healthcare, a long-overdue transformation, and the reflections are felt across the region too. In 2024, the market attracted $25.1 billion globally, reflecting a 5.5-per cent year-on-year increase across thousands of deals. From start-ups to industry giants, tech investment is changing the face of healthcare. AI-driven innovations accounted for nearly half of all digital health advancements globally, with US AI start-ups securing 60 percent of all digital health funding in Q1. A recent report from CB Insights reveals that digital health start-ups across the globe raised $5 billion during the first quarter of this year. This huge investment reflects a trend for fewer, higher-quality deals. In the first quarter of 2025, the average digital health funding deal was $6.4 million, according to the report. The MENA region, Europe, APAC and the Americas have all attracted substantial investments in key areas, including oncology, medical diagnostics, and of course, Artificial Intelligence. 'Oman's healthcare sector is steadily aligning with global trends in digital transformation. From the integration of electronic health records (EHRs) to the adoption of telemedicine and AI-driven diagnostics, the country is embracing innovation to enhance patient care and accessibility,' Dr Viresh Chopra from Oman Dental College says. But with change comes challenges. And in the inertia-heavy, regulation-rich healthcare landscape, the report suggests that the only way to maintain momentum is through global collaboration. Going forward embracing the challenges, the government's commitment to Oman Vision 2040 has further accelerated this progress, encouraging public-private partnerships and investments in health tech. While challenges such as infrastructure and digital literacy remain, Oman's forward-thinking approach signals a promising future where technology and healthcare go hand in hand. 'We are witnessing a clear and progressive shift towards digital transformation in the healthcare sector — both nationally and within our organisation. While global investments, like the $25.1 billion reported by CB Insights in 2024, highlight the momentum of this transformation, Oman is steadily aligning itself with this trend by embracing technology to improve efficiency, patient care and overall health outcomes,' says Ajimsha P A, Head of operations, NMC hospital. Oman's hospitals are witnessing how digital tools are reshaping healthcare delivery. Healthcare providers have invested in Electronic Health Records (EHRs), AI-assisted diagnostics, and cloud-based data systems that streamline operations and reduce administrative burdens. Telemedicine, which gained strong traction during the pandemic, continues to be a critical component in enhancing accessibility for patients, especially in remote areas. Self registration app and pay from home facility, wherein the patient will be directly coming to the outpatient clinic without hassle of waiting in queue and getting the care needed, are the new additions that Oman hospitals would see soon. At the national level, initiatives such as Oman Vision 2040 are driving digitisation across sectors, including healthcare. The Ministry of Health has been proactive in launching digital health portals, mobile apps for appointment bookings and e-prescriptions, and even piloting AI-driven patient monitoring systems. BLURB From the integration of electronic health records (EHRs) to the adoption of telemedicine and AI-driven diagnostics, Oman is embracing innovation to enhance patient care and accessibility
Hans India
07-07-2025
- Health
- Hans India
IIT Delhi launches new online executive programme for AI in Healthcare
New Delhi: In a bid to empower healthcare professionals and technologists with artificial intelligence (AI)-based skills and to revolutionise patient care in the country, the Indian Institute of Technology Delhi (IIT Delhi) has launched a new online programme -- Executive Programme for AI in Healthcare, the institute said on Monday. The 24-week course is designed for clinicians, engineers, data professionals, and med-tech entrepreneurs, under the institute's Continuing Education Programme (CEP). It will equip participants with future-ready skills to drive innovation in patient care, diagnostics, public health, and hospital operations. 'At IIT Delhi's CEP, our mission is to build next-gen capabilities that respond to India's and the world's evolving healthcare needs. AI is no longer optional -- it's central to modern medicine. This new programme empowers professionals to lead that transformation,' said Professor Manav Bhatnagar, Head of CEP at IIT Delhi. The online programme offers a strong academic and practical foundation in AI for healthcare. Participants gain hands-on experience with clinical datasets, explore hospital data systems, and learn to build AI models for diagnosis, risk scoring, imaging, and predictive analytics. Starting with core AI and machine learning principles -- accessible to those without technical backgrounds -- it progresses to advanced topics like natural language processing on Electronic Health Records (EHRs), deep learning for medical imaging, healthcare automation, the Internet of Things (IoT) monitoring, and public health analytics. The participants will also develop AI-powered dashboards and decision-support tools, culminating in a capstone project mentored by IIT Delhi faculty. The launch comes at a pivotal time. The World Economic Forum projects AI could add over $150 billion annually to healthcare through improved outcomes and efficiency. In India, NITI Aayog and EY forecast the digital healthcare market, driven by AI diagnostics and remote care, to exceed $37 billion by 2030. The course will be delivered via live, interactive online sessions on weekends, ensuring flexibility for working professionals. Participants will engage with industry experts, med-tech founders, and hospital CIOs in dedicated sessions that focus on real-world deployment strategies and innovation trends. To ensure a seamless learning experience, IIT Delhi has also partnered with TeamLease EdTech as its technology and student success partner. 'Our collaboration with IIT Delhi brings a powerful AI curriculum to those at the heart of healthcare innovation. This programme will prepare professionals to bridge the gap between clinical knowledge and data intelligence, creating solutions that impact lives,' said Shantanu Rooj, Founder and CEO of TeamLease EdTech.
The Hindu
28-06-2025
- Health
- The Hindu
Health officials told to step up measures to counter seasonal diseases
State Commissioner of Family Welfare G. Veerapandian directed the Medical and Health officials across Chittoor district to step up preparedness measures against seasonal diseases given the ongoing monsoon, on Saturday. The virtual session included District Medical and Health Officer (DMHO) D.T. Sudharani and district-level programme officers. The Commissioner informed the officials to adopt and enforce focused strategies to fight malaria, dengue, chikungunya, and diarrhoeal infections. He directed them to launch a series of public awareness campaigns across the district, particularly in the rural areas. Mr. Veerapandian directed the compulsory entry of Electronic Health Records (EHR) for all out-patient cases to streamline treatment at the PHCs and district hospital. He asked the doctors to follow up regularly under the Non-Communicable Diseases (NCD) survey and enhance data entry in low-performing areas. The Commissioner insisted that all deliveries, both at the government and private hospitals, must be recorded in the Health Management Information System (HMIS). Institutional deliveries should be taken up extensively to curb maternal and infant mortality. He said that high-risk pregnancies should be referred to district hospitals. The official suggested that the Medical and Paramedical fraternity should do their best to reduce C-section births. He further focussed on the launching of campaigns to prevent teenage pregnancies.
Business Upturn
26-06-2025
- Business
- Business Upturn
Electronic Health Records (EHR) Market Valued at USD 33.45 Billion in 2024, Set to Grow at 4.59% CAGR Through 2032
By GlobeNewswire Published on June 26, 2025, 05:00 IST San Francisco, USA, June 25, 2025 (GLOBE NEWSWIRE) — The Electronic Health Records (EHR) market was valued at USD 33,451.20 million in 2024 and is projected to grow at a CAGR of 4.59% from 2025 to 2032. This growth is driven by the global shift toward digital healthcare infrastructure, government mandates for record standardization, and the rising demand for efficient patient data management across hospitals, clinics, and ambulatory care centers. EHR systems are digital versions of a patient's paper chart, offering real-time, patient-centered records that make information instantly and securely available to authorized users. They are critical for improving coordination between care providers, minimizing medical errors, and enhancing overall clinical outcomes. Government initiatives worldwide are playing a key role in promoting EHR adoption. Programs such as the U.S. HITECH Act, the EU's digital health transformation goals, and India's Ayushman Bharat Digital Mission are pushing healthcare providers toward digitization. At the same time, the rise of value-based care, telehealth, and mobile health applications has increased the need for interoperable and cloud-based EHR systems. The market is witnessing significant technological advancements, including integration with AI, predictive analytics, and mobile platforms, which enable better clinical decision-making and patient engagement. However, challenges such as high implementation costs, data privacy concerns, and interoperability issues between different systems remain key hurdles, particularly in emerging markets. North America dominates the global EHR market, backed by strong digital infrastructure and initiatives like the U.S. HITECH Act, which allocated over $35 billion to promote EHR adoption. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, fueled by rising healthcare investments—India's health budget rose 13% in 2023—and national digitization drives like China's 'Healthy China 2030.' Supportive policies, growing urbanization, and expanding patient volumes are accelerating EHR integration across the region, attracting global players and investors alike. Unlock in-depth insights and forecasts – Get your FREE sample report of the EHR market today: Key Players- Detailed Competitive Insights Cerner Corporation GE Healthcare Veradigm LLC Epic Systems Corporation eClinicalWorks Greenway Health, LLC NextGen Healthcare, Inc. Medical Information Technology, Inc. CPSI AdvancedMD, Inc. Allscripts Healthcare Solutions MEDHOST Athenahealth McKesson Corporation Siemens Healthineers Oracle Corporation Market Dynamics Drivers Government Mandates and Incentives: Many countries are accelerating Electronic Health Records (EHR) adoption through targeted policies. In the U.S., CMS's Promoting Interoperability Program ties Medicare reimbursements to EHR usage. Germany's Hospital Future Act allocated €4.3 billion for digital upgrades, while Australia's My Health Record achieved over 90% population coverage. India's Ayushman Bharat Digital Mission aims to create a unified health ID system, promoting seamless data exchange. These initiatives are driving global healthcare digitalization and fostering integrated patient care systems. Rising Demand for Streamlined Healthcare Delivery: For example, Mayo Clinic uses integrated EHRs to reduce duplication, streamline workflows, and access real-time patient data—cutting documentation time and improving care coordination across departments and specialties. Growth in Telehealth and Remote Monitoring: The global shift toward telemedicine post-COVID-19 has increased the need for centralized digital records that can be accessed remotely. This trend is pushing both public and private healthcare providers to invest in cloud-based and interoperable EHR systems. Data-Driven Decision Making in Healthcare: As data becomes a core asset in personalized medicine and value-based care models, EHRs serve as critical repositories of patient history, lab reports, medications, and imaging data. Challenges High Implementation and Maintenance Costs : The cost of deploying EHR software, training staff, and maintaining IT infrastructure can be prohibitive for small healthcare facilities, especially in developing nations. : The cost of deploying EHR software, training staff, and maintaining IT infrastructure can be prohibitive for small healthcare facilities, especially in developing nations. Interoperability and Data Security Concerns: Although EHRs are designed to improve information sharing, achieving true interoperability across different systems remains a challenge. Moreover, the sensitive nature of health data makes security and compliance with data protection regulations (like HIPAA and GDPR) a critical issue. Opportunities Integration with AI and analytics in EHRs enables predictive insights—such as Mount Sinai Hospital using AI models within EHRs to identify sepsis risk early, improving response time and patient outcomes. This innovation is driving demand for intelligent, data-driven systems. in EHRs enables predictive insights—such as Mount Sinai Hospital using AI models within EHRs to identify sepsis risk early, improving response time and patient outcomes. This innovation is driving demand for intelligent, data-driven systems. Mobile and Cloud-Based EHRs: The adoption of mobile health apps and cloud platforms enables real-time access to health data, especially beneficial in rural and underserved regions. Regional Insights North America North America holds 42.50% of the global EHR market, driven by the U.S.'s early adoption and digital health funding. Epic Systems powers major hospital networks like Kaiser Permanente, while Canada's Infoway initiative accelerates EHR integration, ensuring secure, interoperable data across provinces. Europe Europe is a mature yet fragmented market for EHRs. Countries like Germany, the UK, and the Netherlands are progressing well in EHR integration, while others lag due to privacy concerns and inconsistent digital policies. The EU's push toward unified health records under the European Health Data Space initiative could streamline EHR adoption across member states. Asia-Pacific The Asia-Pacific region is projected to witness the fastest growth during the forecast period. Rapid urbanization, increased healthcare spending, and the digitalization efforts in countries like India, China, and Australia are major contributors. Government-backed programs such as India's Ayushman Bharat Digital Mission and China's Smart Healthcare initiative are significantly driving EHR deployment. Latin America & Middle East Both regions are gradually embracing EHR systems. Brazil, Saudi Arabia, and the UAE have initiated digital health reforms. However, budget constraints and a lack of infrastructure remain key barriers. International partnerships and private investments are expected to unlock growth potential in these markets. TABLE OF CONTENT 1. Electronic Health Records Market Overview1.1. Study Scope1.2. Market Estimation Years 2. Executive Summary 2.1. Market Snippet2.1.1. Electronic Health Records Market Snippet By Product2.1.2. Electronic Health Records Market Snippet By Type2.1.3. Electronic Health Records Market Snippet By Business Model2.1.4. Electronic Health Records Market Snippet By Application2.1.5. Electronic Health Records Market Snippet By End Use2.1.6. Electronic Health Records Market Snippet by Country2.1.7. Electronic Health Records Market Snippet by Region2.2. Competitive Insights 3. Electronic Health Records Key Market Trends 3.1. Electronic Health Records Market Drivers3.1.1. Impact Analysis of Market Drivers3.2. Electronic Health Records Market Restraints3.2.1. Impact Analysis of Market Restraints3.3. Electronic Health Records Market Opportunities3.4. Electronic Health Records Market Future Trends 4. Electronic Health Records Industry Study 4.1. PEST Analysis4.2. Porter's Five Forces Analysis4.3. Growth Prospect Mapping4.4. Regulatory Framework Analysis 5. Electronic Health Records Market: Impact of Escalating Geopolitical Tensions 5.1. Impact of COVID-19 Pandemic5.2. Impact of Russia-Ukraine War5.3. Impact of Middle East Conflicts 6. Electronic Health Records Market Landscape 6.1. Electronic Health Records Market Share Analysis, 20246.2. Breakdown Data, by Key Manufacturer6.2.1. Established Players' Analysis6.2.2. Emerging Players' Analysis 7. Electronic Health Records Market – By Product 7.1. Overview7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)7.1.2. On-premises7.1.3. Web & Cloud-Based EHR 8. Electronic Health Records Market – By Type 8.1. Overview8.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)8.1.2. Acute8.1.3. Outpatient8.1.4. Post Acute 9. Electronic Health Records Market – By Business Model 9.1. Overview9.1.1. Segment Share Analysis, By Business Model, 2024 & 2032 (%)9.1.2. Licensed Software9.1.3. Technology Resale9.1.4. Subscriptions9.1.5. Professional Services9.1.6. Others 10. Electronic Health Records Market – By Application 10.1. Overview10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)10.1.2. Cardiology10.1.3. Neurology 10.1.4. Radiology ……… Reasons to Invest in the EHR Market Essential Role in Modern Healthcare Systems EHRs are no longer optional but a fundamental part of modern healthcare. As hospitals strive to improve patient care, safety, and efficiency, EHRs serve as a backbone for digital health ecosystems. Regulatory Push and Compliance Standards Investment in compliant EHR systems helps healthcare providers align with stringent data protection laws while avoiding penalties and securing patient trust. Increasing Healthcare Expenditure Globally, healthcare budgets are expanding. A significant portion is being directed toward digital infrastructure, making EHR vendors prime beneficiaries of government and institutional funding. Rising Adoption of Cloud and AI Technologies EHR vendors integrating cloud capabilities and AI features offer enhanced scalability, analytics, and patient engagement. These smart EHRs are more future-proof and attractive to investors. Long-Term Cost Benefits for Healthcare Providers Despite initial costs, EHR systems lead to long-term savings by reducing administrative workload, avoiding duplication of tests, and minimizing errors. Future Outlook The Electronic Health Records (EHR) market is poised for a tech-driven evolution, with AI integration, cloud-based platforms, and interoperability leading the way. By 2032, real-time data exchange, as seen in the U.K.'s NHS Federated Data Platform and India's Ayushman Bharat Digital Mission, will become standard. Growing cybersecurity investments and patient-centric innovations are redefining EHR functionality. With global healthcare systems embracing value-based care, the market is set for intelligent, adaptive, and patient-connected growth worldwide. Discover the Full Study : Explore More Research Titles in the Healthcare Category by AnalystView Market Insights: Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
